Sign in

NCT05968898Recruiting

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

This is a pragmatic clinical trial that will study the effect of a radiomics-based computer-aided diagnosis (CAD) tool on clinicians' management of pulmonary nodules (PNs) compared to usual care. Adults aged 35-89 years with 8-30mm PNs evaluated at Penn Medicine PN clinics will undergo 1:1 randomization to one of two groups, defined by the PN malignancy risk stratification strategy used by evaluating clinicians: 1) usual care or 2) usual care + use of a radiomics-based CAD tool.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
21 Jul 2023
Start date
9 Jan 2024
Primary completion date
31 Jul 2029
Lead sponsor
Abramson Cancer Center at Penn Medicine
Diseases
Lung cancer
NCT number
NCT05968898

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 9 Jan 2024 to the primary completion date, 31 Jul 2029
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • PN previously seen on CT imaging \>60 days prior to most recent CT
  • History of active cancer within the previous 5 years
  • Presence of a thoracic implant that impedes PN visualization

Other illness

  • Pure ground-glass subsolid PNs (may be associated with lower risk of clinically significant malignancy)
  • History of lung cancer

Other

  • Chest CT imaging with discrete mediastinal or hilar lymphadenopathy by CT size criteria (\>10mm in maximal short-axis diameter on axial CT images)
  • PNs with popcorn calcification (consistent with benign etiology)
  • More than one indeterminate PN 8-30mm in maximal diameter

Who the study is looking for

  • Male or female, aged 35-89 years
  • Scheduled to be evaluated at a UPHS PN clinic
  • Newly discovered solid or part-solid indeterminate PN 8-30mm in maximal diameter on CT imaging within 60 days of index clinic visit
  • Chest CT imaging meeting the technical requirements for compatibility with Optellum Virtual Nodule Clinic software

Age in the registry: 35 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Penn Medicine University City
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Penn Medicine Washington Square
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Perelman Center for Advanced Medicine
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.